22nd Century is a plant biotechnology company and the global leader in modifying the content of nicotinic alkaloids in plants, including the tobacco plant, through genetic engineering and plant breeding. The company develops innovative plant lines with combinations of new and/or enhanced traits. We own or exclusively control 97 issued patents in 79 countries where at least 75% of the world\'s smokers reside. 22nd Century\'s business segments are primarily smoking cessation products and modified risk tobacco products.